| Abbvie Inc. | 4,369 | US$1.1M | 8.2% |
| Amgen Inc. | 1,876 | US$679K | 5.0% |
| Gilead Sciences, Inc. | 4,786 | US$605K | 4.5% |
| Vertex Pharmaceuticals Incorporated | 1,170 | US$581K | 4.3% |
| Regeneron Pharmaceuticals, Inc. | 633 | US$395K | 2.9% |
| Revolution Medicines, Inc. | 1,781 | US$334K | 2.5% |
| Alnylam Pharmaceuticals, Inc. | 1,055 | US$318K | 2.4% |
| Beone Medicines Ltd. Class A | 1,026 | US$292K | 2.2% |
| Moderna, Inc. | 4,130 | US$289K | 2.1% |
| Biogen Inc. | 1,325 | US$286K | 2.1% |
| Natera, Inc. | 1,050 | US$285K | 2.1% |
| Royalty Pharma Plc | 4,830 | US$271K | 2.0% |
| Illumina, Inc. | 1,481 | US$260K | 1.9% |
| Insmed Incorporated | 2,262 | US$241K | 1.8% |
| United Therapeutics Corporation | 428 | US$232K | 1.7% |
| Guardant Health, Inc. | 1,542 | US$231K | 1.7% |
| Roivant Sciences Ltd. | 6,308 | US$223K | 1.7% |
| Incyte Corporation | 1,920 | US$218K | 1.6% |
| Viatris Inc. | 13,157 | US$209K | 1.5% |
| Neurocrine Biosciences, Inc. | 1,216 | US$205K | 1.5% |
| Argenx Se | 215 | US$199K | 1.5% |
| Jazz Pharmaceuticals Plc | 791 | US$191K | 1.4% |
| Bridgebio Pharma, Inc. | 2,499 | US$186K | 1.4% |
| Ionis Pharmaceuticals, Inc. | 2,295 | US$182K | 1.3% |
| Cytokinetics, Incorporated | 2,133 | US$182K | 1.3% |
| Exelixis, Inc. | 3,292 | US$179K | 1.3% |
| Alkermes Plc | 3,375 | US$177K | 1.3% |
| Arrowhead Pharmaceuticals, Inc. | 2,061 | US$168K | 1.2% |
| Biomarin Pharmaceutical Inc. | 2,915 | US$167K | 1.2% |
| Astrazeneca Plc | 870 | US$165K | 1.2% |
| Halozyme Therapeutics, Inc. | 2,014 | US$158K | 1.2% |
| Crispr Therapeutics Ag | 2,857 | US$156K | 1.2% |
| Vaxcyte, Inc. | 2,675 | US$155K | 1.2% |
| Tg Therapeutics, Inc. | 2,657 | US$146K | 1.1% |
| Medpace Holdings, Inc. | 262 | US$139K | 1.0% |
| Apogee Therapeutics, Inc. | 1,034 | US$137K | 1.0% |
| Cogent Biosciences, Inc. | 3,488 | US$135K | 1.0% |
| Twist Bioscience Corporation | 1,289 | US$133K | 0.98% |
| Ptc Therapeutics, Inc. | 1,625 | US$133K | 0.98% |
| Nuvalent, Inc. | 1,072 | US$132K | 0.98% |
| Scholar Rock Holding Corporation | 2,407 | US$132K | 0.98% |
| Axsome Therapeutics, Inc. | 528 | US$129K | 0.96% |
| Cg Oncology, Inc. | 1,814 | US$129K | 0.96% |
| Krystal Biotech, Inc. | 335 | US$125K | 0.92% |
| Viking Therapeutics, Inc. | 3,094 | US$121K | 0.90% |
| Travere Therapeutics, Inc. | 2,124 | US$121K | 0.90% |
| Protagonist Therapeutics, Inc. | 974 | US$119K | 0.89% |
| Ascendis Pharma A/s | 447 | US$119K | 0.88% |
| Veracyte, Inc. | 2,012 | US$118K | 0.88% |
| Liquidia Corporation | 1,457 | US$116K | 0.86% |
| Kymera Therapeutics, Inc. | 978 | US$112K | 0.83% |
| Madrigal Pharmaceuticals, Inc. | 199 | US$107K | 0.79% |
| Ultragenyx Pharmaceutical Inc. | 3,106 | US$104K | 0.77% |
| Beam Therapeutics Inc. | 2,915 | US$100K | 0.74% |
| Immunitybio, Inc. | 11,362 | US$99,474 | 0.74% |
| Mirum Pharmaceuticals, Inc. | 849 | US$99,392 | 0.74% |
| Praxis Precision Medicines, Inc. | 290 | US$97,089 | 0.72% |
| Rhythm Pharmaceuticals, Inc. | 867 | US$96,263 | 0.71% |
| Acadia Pharmaceuticals Inc. | 3,792 | US$95,938 | 0.71% |
| Intellia Therapeutics, Inc. | 5,161 | US$87,324 | 0.65% |
| Arcutis Biotherapeutics, Inc. | 3,227 | US$84,612 | 0.63% |
| Recursion Pharmaceuticals, Inc. | 20,066 | US$73,642 | 0.55% |
| Sarepta Therapeutics, Inc. | 4,066 | US$73,066 | 0.54% |
| Summit Therapeutics Inc. | 4,911 | US$71,553 | 0.53% |
| Adma Biologics Inc | 8,088 | US$67,697 | 0.50% |
| Celcuity Inc. | 582 | US$60,889 | 0.45% |
| Grail, Inc. | 751 | US$51,271 | 0.38% |
| Soleno Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Apellis Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |